Annual Cash & Cash Equivalents:
$4.90M-$3.06M(-38.49%)Summary
- As of today, RGC annual cash & cash equivalents is $4.90 million, with the most recent change of -$3.06 million (-38.49%) on June 1, 2025.
- During the last 3 years, RGC annual cash & cash equivalents has fallen by -$11.52 million (-70.17%).
- RGC annual cash & cash equivalents is now -70.17% below its all-time high of $16.42 million, reached on June 30, 2022.
Performance
RGC Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
N/ASummary
- RGC quarterly cash & cash equivalents is not available.
Performance
RGC Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RGC Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -38.5% | - |
| 3Y3 Years | -70.2% | - |
| 5Y5 Years | +1165.4% | - |
RGC Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -70.2% | at low | ||
| 5Y | 5-Year | -70.2% | +8144.1% | ||
| All-Time | All-Time | -70.2% | +8144.1% |
RGC Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | $4.90M(-38.5%) | - |
| Jun 2024 | $7.96M(-31.2%) | $2.96M(+89.2%) |
| Jun 2023 | $11.56M(-29.6%) | $1.56M(-75.6%) |
| Jun 2022 | $16.42M(>+9900.0%) | $6.42M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | $59.40K(-84.7%) | $59.40K(-80.6%) |
| Dec 2020 | - | $306.00K(-20.9%) |
| Jun 2020 | $387.00K(+59.1%) | $387.00K |
| Jun 2019 | $243.30K | - |
FAQ
- What is Regencell Bioscience Holdings Limited annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Regencell Bioscience Holdings Limited?
- What is Regencell Bioscience Holdings Limited annual cash & cash equivalents year-on-year change?
- What is the all-time high quarterly cash & cash equivalents for Regencell Bioscience Holdings Limited?
What is Regencell Bioscience Holdings Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of RGC is $4.90M
What is the all-time high annual cash & cash equivalents for Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited all-time high annual cash & cash equivalents is $16.42M
What is Regencell Bioscience Holdings Limited annual cash & cash equivalents year-on-year change?
Over the past year, RGC annual cash & cash equivalents has changed by -$3.06M (-38.49%)
What is the all-time high quarterly cash & cash equivalents for Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited all-time high quarterly cash & cash equivalents is $6.42M